Eur Respir J 1997; 10: 219-225
Copyright © ERS Journals Ltd 1997
Physiology and pathophysiology of pleural fluid turnover
G Miserocchi
The pleural space contains a tiny amount (approximately 0.3 mL.kg-1) of hypooncotic fluid (approximately 1 g.dL-1 protein). Pleural fluid turnover is estimated to be approximately 0.15 mL.kg-1.h-1. Pleural fluid is produced at parietal pleural level, mainly in the less dependent regions of the cavity. Reabsorption is accomplished by parietal pleural lymphatics in the most dependent part of the cavity, on the diaphragmatic surface and in the mediastinal regions. The flow rate in pleural lymphatics can increase in response to an increase in pleural fluid filtration, acting as a negative feedback mechanism to control pleural liquid volume. Such control is very efficient, as a 10 fold increase in filtration rate would only result in a 15% increase in pleural liquid volume. When filtration exceeds maximum pleural lymphatic flow, pleural effusion occurs: as an estimate, in man, maximum pleural lymph flow could attain 30 mL.h-1, equivalent to approximately 700 mL.day-1 (approximately 40% of overall lymph flow). Under physiological conditions, the lung interstitium and the pleural space behave as functionally independent compartments, due to the low water and solute permeability of the visceral pleura. Pleural fluid circulates in the pleural cavity and intrapleural fluid dynamics may be represented by a porous flow model. Lubrication between lung and chest wall is assured by oligolamellar surfactant molecules stratified on mesothelial cells of the opposing pleurae. These molecules carry a charge of similar sign and, therefore, repulse each other, assuring a graphite-like lubrication.
This article has been cited by other articles:

|
 |

|
 |
 
V. K. Kouritas, C. Hatzoglou, K. I. Gourgoulianis, and P. A. Molyvdas
Pleural electrophysiology variations according to location in pleural cavity
Interactive CardioVascular and Thoracic Surgery,
September 1, 2009;
9(3):
391 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-G. Nie, T. Tucker, X.-F. Su, T. Na, J.-B. Peng, P. R. Smith, S. Idell, and H.-L. Ji
Expression and Regulation of Epithelial Na+ Channels by Nucleotides in Pleural Mesothelial Cells
Am. J. Respir. Cell Mol. Biol.,
May 1, 2009;
40(5):
543 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Hawkins, M. C. Petrie, P. S. Jhund, G. W. Chalmers, F. G. Dunn, and J. J.V. McMurray
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
Eur J Heart Fail,
February 1, 2009;
11(2):
130 - 139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Kouritas, C. Hatzoglou, C. N. Foroulis, and K. I. Gourgoulianis
Human parietal pleura present electrophysiology variations according to location in pleural cavity
Interactive CardioVascular and Thoracic Surgery,
August 1, 2008;
7(4):
544 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I M Balfour-Lynn, E Abrahamson, G Cohen, J Hartley, S King, D Parikh, D Spencer, A H Thomson, D Urquhart, and on behalf of the Paediatric Pleural Diseases Subco
BTS guidelines for the management of pleural infection in children
Thorax,
February 1, 2005;
60(suppl_1):
i1 - i21.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marchi, L. R. Teixeira, F. Vargas, P. Astoul, A. Fraticelli, A. Robaglia-Schlupp, and P. Cau
Talc for Pleurodesis: Hero or Villain?
Chest,
July 1, 2003;
124(1):
416 - 417.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Antunes, E Neville, J Duffy, and N Ali
BTS guidelines for the management of malignant pleural effusions
Thorax,
May 1, 2003;
58(90002):
ii29 - 38.
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Zocchi
Physiology and pathophysiology of pleural fluid turnover
Eur. Respir. J.,
December 1, 2002;
20(6):
1545 - 1558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Borok and A. S. Verkman
Lung Edema Clearance: 20 Years of Progress: Invited Review: Role of aquaporin water channels in fluid transport in lung and airways
J Appl Physiol,
December 1, 2002;
93(6):
2199 - 2206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Mitrouska and D. Bouros
The Trans-Exudative Pleural Effusion
Chest,
November 1, 2002;
122(5):
1503 - 1505.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A H Thomson, J Hull, M R Kumar, C Wallis, and I M Balfour Lynn
Randomised trial of intrapleural urokinase in the treatment of childhood empyema
Thorax,
April 1, 2002;
57(4):
343 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D'Alessandro, G. Muzi, A. Monaco, S. Filiberto, A. Barboni, and G. Abbritti
Yellow nail syndrome: does protein leakage play a role?
Eur. Respir. J.,
January 1, 2001;
17(1):
149 - 152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Song, B. Yang, M. A. Matthay, T. Ma, and A. S. Verkman
Role of aquaporin water channels in pleural fluid dynamics
Am J Physiol Cell Physiol,
December 1, 2000;
279(6):
C1744 - C1750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. NOPPEN, M. DE WAELE, R. LI, K. V. GUCHT, J. D'HAESE, E. GERLO, and W. VINCKEN
Volume and Cellular Content of Normal Pleural Fluid in Humans Examined by Pleural Lavage
Am. J. Respir. Crit. Care Med.,
September 1, 2000;
162(3):
1023 - 1026.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Leukotriene-receptor antagonists and related compounds
Can. Med. Assoc. J.,
November 1, 1999;
161(90111):
s31 - 34.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. HERMANS, O. LESUR, B. WEYNAND, TH. PIETERS, M. LAMBERT, and A. BERNARD
Clara Cell Protein (CC16) in Pleural Fluids . A Marker of Leakage through the Visceral Pleura
Am. J. Respir. Crit. Care Med.,
March 1, 1998;
157(3):
962 - 969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O Eickelberg, C. Sommerfeld, C Wyser, M Tamm, F Reichenberger, P. Bardin, M Soler, M Roth, and A. Perruchoud
MMP and TIMP expression pattern in pleural effusions of different origins
Am. J. Respir. Crit. Care Med.,
December 1, 1997;
156(6):
1987 - 1992.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the European Respiratory Society.
|